# Shengshan Capital

> Shengshan Capital is a VC fund backing Biotechnology, Health Care and AgTech. See 3 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jun 2023
- Lead investor: 33%
- Last updated: Aug 2026

Shengshan Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Health Care | 2 | 67% |
| AgTech | 1 | 33% |
| Genetics | 1 | 33% |
| Software | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Changjin Biotechnology | Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins. |  | Series A | Jun 06, 2023 |  |
| Konfoong Biotech International | KFBIO’s uses big data, cloud computing and AI to quickly and reliably scan and digitise images, making them easier to share with experts to improve the speed and accuracy of diagnosis. | $14.9M | Series C | Jul 12, 2022 |  |
| Tekeluo Biotech | Tekeluo Biotech is a Healthcare company. | $4.5M | Series A | Aug 01, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [Ascendin Fund](https://shizune.co/investors/profile/ascendin-fund) — VC Fund, 1 deal together
- [Huiyuan Capital](https://shizune.co/investors/profile/huiyuan-capital) — VC Fund, 1 deal together
- [Jinqiu Capital](https://shizune.co/investors/profile/jinqiu-fund) — VC Fund, 1 deal together
- [JMCR Partners](https://shizune.co/investors/profile/jmcr-partners) — VC Fund, 1 deal together
- [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital) — VC Fund, 1 deal together
- [Viva Ventures Biotech Fund](https://shizune.co/investors/profile/viva-ventures-biotech-group) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)

## FAQ

### What does Shengshan Capital invest in?

Shengshan Capital invests primarily in Biotechnology, Health Care and AgTech startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Shengshan Capital last invest?

The most recent investment recorded for Shengshan Capital closed in Jun 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co